Skip to main content
Clinical Trials/KCT0009467
KCT0009467
Recruiting
未知

The efficacy of steroid usage in patients undergoing surgery for intradural spinal cord tumors: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Asan Medical Center0 sites56 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Asan Medical Center
Enrollment
56
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Adults aged 19 years and above
  • (2\) Patients diagnosed with neurofibroma or meningioma within the thoracic spinal cord
  • (3\) Patients capable of walking with a muscle strength of 3 or higher on the Medical Research Council (MRC) scale for lower limbs
  • (4\) Patients willing to participate in the study, adhere to treatment and procedures, and visit the hospital for all follow\-up evaluations
  • (5\) Patients who have received explanations regarding the purpose, methods, and effects of the study and have voluntarily signed the informed consent form

Exclusion Criteria

  • (1\) Patients who are either under 18 years of age or 66 years of age and older
  • (2\) Patients deemed by the investigator to be ineligible for spinal surgery under general anesthesia due to significant cardiovascular, pulmonary, hepatic, or renal dysfunction
  • (3\) Patients with diabetes mellitus
  • (4\) Patients with gastrointestinal disorders including gastritis and gastric ulcers
  • (5\) Patients with hypersensitivity reactions or adverse effects to steroids
  • (6\) Patients with infections in joint spaces, bursae, tendon sheaths, or around tendons
  • (7\) Patients receiving live bacterial vaccines
  • (8\) Patients with herpes simplex, herpes zoster, or chickenpox
  • (9\) Patients with infections where effective antimicrobial therapy is not available or systemic fungal infections
  • (10\) Patients receiving immunosuppressive therapy

Outcomes

Primary Outcomes

Not specified

Similar Trials